Artivion (AORT) Change in Cash (2010 - 2026)
Artivion (AORT) posted Change in Cash of -$9.1 million for Q1 2026, down 7.35% on a QoQ basis from -$8.5 million in Q4 2025, and up 42.02% year-over-year from -$6.4 million in Q1 2025.
Artivion (AORT) Change in Cash (2010 - 2026) Analysis & Trends
Artivion's Change in Cash history runs 17 years deep, the most recent figure standing at -$9.1 million for Q1 2026.
- Quarterly Change in Cash rose 42.02% year-over-year to -$9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.1 million (up 234.61% YoY) and the FY2025 annual result came in at $11.4 million, up 308.96% from the prior year.
- Change in Cash was -$9.1 million for Q1 2026 at Artivion, down from -$8.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $20.0 million in Q3 2025 and bottomed at -$15.8 million in Q1 2025.
- A 5-year average of $44352.9 and a median of -$2.7 million in 2024 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 1628.77% in 2025, while the deepest fall reached 214.32% in 2025.
- Artivion's Change in Cash stood at $1.8 million in 2022, then surged by 206.86% to $5.5 million in 2023, then slumped by 149.64% to -$2.7 million in 2024, then sank by 214.32% to -$8.5 million in 2025, then slipped by 7.35% to -$9.1 million in 2026.
- Business Quant data shows AORT's Change in Cash at -$9.1 million in Q1 2026, -$8.5 million in Q4 2025, and $20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | -9.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.14 Mn |
| Dec 31, 2025 | -8.52 Mn |
| Sep 30, 2025 | 19.95 Mn |
| Jun 30, 2025 | 15.78 Mn |
| Mar 31, 2025 | -15.77 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | -7.82 Mn |
| Dec 31, 2023 | 5.46 Mn |
| Sep 30, 2023 | 4.71 Mn |
| Jun 30, 2023 | 18.00 Mn |
| Mar 31, 2023 | -8.58 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | -2.81 Mn |
| Jun 30, 2022 | -11.03 Mn |
| Mar 31, 2022 | -3.60 Mn |
| Dec 31, 2021 | -10.12 Mn |
| Sep 30, 2021 | 14.10 Mn |
| Jun 30, 2021 | -6.08 Mn |